Physician profile
Beth Summers
NPI 1639521578
$2,986.23
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $158 · 2020: $111 · 2021: $2,670 · 2022: $47.73.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Art Optical Contact Lens INC. | $2,400.00 | 2021 | |
| Eyevance Pharmaceuticals LLC | $199.31 | 2021 | |
| Sun Pharmaceutical Industries INC. | $171.95 | 2019-2022 | |
| Allergan, INC. | $143.63 | 2019-2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $17.34 | 2020 | |
| Aerie Pharmaceuticals, INC. | $15.37 | 2020 | |
| Alcon Vision LLC | $14.06 | 2021 | |
| Dompe US, INC. | $12.61 | 2021 | |
| Optos, INC. | $11.96 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beth Summers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.